Adage Capital Partners Gp, L.L.C. Geron Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Geron Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 28,875,000 shares of GERN stock, worth $112 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
28,875,000
Previous 19,725,000
46.39%
Holding current value
$112 Million
Previous $83.6 Million
56.74%
% of portfolio
0.24%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
273Shares Held
491MCall Options Held
1.62MPut Options Held
670K-
Black Rock Inc. New York, NY46.6MShares$180 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$171 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$126 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$125 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$112 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.46B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...